CPAP Therapy

How CPAP works

Obstructive sleep apnea is a mechanical problem: the upper airway repeatedly collapses during sleep when the muscles supporting it relax. Each collapse interrupts breathing, drops blood oxygen, and triggers a brief micro-arousal as the brain restarts breathing. The pattern repeats five to thirty or more times per hour throughout the night. The cumulative effect — fragmented sleep plus repeated oxygen swings — is what produces the daytime symptoms and the long-term cardiovascular consequences.

CPAP addresses the mechanical problem mechanically. A small electric blower delivers a continuous stream of pressurized air through a hose to a mask worn over the nose, mouth, or both. The pressure acts as a pneumatic splint, holding the upper airway open against the relaxation forces that would otherwise allow it to collapse. As long as the mask is sealed and the prescribed pressure is delivered, the airway cannot close. Apnea events do not occur. Oxygen stays normal. Sleep architecture rebuilds — deep sleep and REM sleep return to normal proportions, often within the first weeks of consistent use.

The pressure level is determined by a sleep study (an in-lab titration or, increasingly, by auto-adjusting CPAP devices that sample airway resistance and adjust in real time). For most adults with OSA, prescribed pressures fall in the range of six to fifteen centimeters of water. Higher pressures may be required for severe OSA or for patients whose airway behavior changes substantially with body position or sleep stage.

The adherence problem (which is the whole game)

The clinical literature on CPAP outcomes is shaped fundamentally by adherence. Patients who use CPAP four or more hours per night, most nights, derive measurable benefit — lower blood pressure, reduced atrial fibrillation recurrence, improved daytime alertness, better cognitive function, and substantial reduction in long-term cardiovascular events. Patients with poor adherence — partial-night use, frequent gaps, removing the mask in the early morning hours — derive much less benefit, and in some studies, almost none.

This pattern explains an apparent paradox in the CPAP outcome literature. Headline randomized trial findings on CPAP and cardiovascular outcomes have produced mixed signals — some trials showing benefit, some showing only modest effects. Secondary analyses consistently reveal the explanation: when adherence is included as a stratifying variable, patients who actually used the device produced clearer benefit, while patients with poor adherence pulled the average toward null. The therapy works; the issue is who uses it.

Adherence rates are known to be low. Population studies put one-year CPAP adherence at roughly fifty to seventy percent, depending on definition and population. A meaningful portion of patients prescribed CPAP either never start it, abandon it within months, or use it sporadically without crossing the four-hours-per-night threshold. The reasons are tractable — most are mechanical (mask fit, pressure tolerance, nasal congestion, claustrophobia) and behavioral (ramp-up patterns, partner-related friction, travel and routine disruption) rather than fundamental incompatibility.

The clinical principle worth knowing: most CPAP "failures" are not failures of the therapy. They are problems with mask fit, pressure adjustment, nasal congestion, or initial acclimation that have specific solutions when worked through with a good sleep clinician or DME provider. Patients who give up on CPAP after a difficult first month often had readily-solvable problems that no one walked them through.

Common challenges and what actually fixes them

The early weeks of CPAP use are where most adherence problems develop and where most are also solvable. The challenges below are the ones reported most often, with the interventions that have empirical support.

Mask fit issues. Mask discomfort, leaks, and pressure points are the most common early complaint and the most fixable. Multiple mask styles exist — nasal pillows (small inserts that seal at the nostrils), nasal masks (covering only the nose), full-face masks (covering nose and mouth), and hybrid designs. Most patients try two or three masks before finding the one that works. A good DME provider will swap masks at no cost during the trial period; insistence on this is reasonable. The "ideal" mask depends on how the patient breathes (mouth breathers need full-face or mouth-taping plus nasal), facial structure, and tolerance for skin contact.

Pressure intolerance. Difficulty tolerating the delivered pressure, particularly on exhale, is a common complaint. Most modern CPAP devices include a feature called expiratory pressure relief or A-flex (varies by manufacturer) that briefly drops pressure during exhale. Bilevel positive airway pressure (BiPAP) — different pressures for inhale and exhale — is an option for patients who cannot tolerate CPAP. Auto-adjusting CPAP (APAP) starts at lower pressures and increases only as needed, often easing the acclimation curve.

Nasal congestion or dryness. The pressurized airflow can produce nasal symptoms in patients who didn't have them before. Heated humidification (built into most modern devices) substantially reduces this. Saline nasal sprays before bed, and treatment of underlying allergic rhinitis when present, both help.

Claustrophobia. Anxiety about the mask is more common than people initially report. Desensitization protocols — wearing the mask without pressure during the day for short periods, gradually building to overnight use — work for most patients with anxiety-driven non-adherence. Nasal pillow masks (which do not enclose the face) are often easier for claustrophobic patients than full-face masks.

Bed partner concerns. Mask noise, hose disruption, and the visual change can affect bed partners' sleep too. Modern devices are quiet (most well below conversational volume), and most disruption resolves within a few weeks of acclimation. Some couples find that the elimination of snoring more than compensates for the device itself.

Travel and routine disruption. Maintaining adherence on travel, hospital stays, and during illness is a real challenge. Travel CPAP devices are smaller and battery-capable. The clinical recommendation is consistent: bring the device on every trip; do not skip use during illness unless specifically directed by a clinician. Each missed night reverts the airway to its untreated state.

CPAP variants — what the device acronyms mean

The "CPAP" label covers several related devices that differ in how pressure is delivered. The choice depends on individual airway behavior and tolerance.

CPAP (continuous positive airway pressure). The original device. Constant pressure throughout the breath cycle, set at the level determined by the titration study. Simplest mechanism, generally the cheapest, well-suited to patients whose airway behavior is consistent across the night.

APAP (auto-adjusting positive airway pressure). The most common modern prescription. The device samples airway resistance breath by breath and adjusts pressure within a prescribed range. Often easier to tolerate during acclimation because pressures start low and increase only when needed. Useful for patients whose airway behavior varies — by sleep stage, body position, or alcohol use.

BiPAP or BPAP (bilevel positive airway pressure). Two distinct pressures — higher on inhale, lower on exhale — easier on the breathing muscles than constant pressure. Used for patients who cannot tolerate standard CPAP, for those with very high pressure requirements, and for some patients with comorbid respiratory conditions.

ASV (adaptive servo-ventilation). A more sophisticated bilevel device used primarily for central sleep apnea (a different condition involving disordered respiratory drive rather than airway collapse). Not typical for OSA. Worth knowing about because central sleep apnea sometimes emerges in patients with heart failure or after long-term opioid use, and the device profile differs from standard OSA treatment.

The choice among these is appropriately a clinical decision made with a sleep specialist based on the titration findings and individual response. For most patients with OSA, APAP is the default first prescription, with adjustments based on response and tolerance.

What CPAP success looks like

Patients often expect dramatic next-day improvement after starting CPAP. The actual trajectory is more gradual and arguably more durable. The first nights of CPAP use are typically uncomfortable as the patient acclimates to the mask, the airflow, and the device sounds. Sleep quality may initially decrease before it improves. By the end of the first one to two weeks, most patients with adequate mask fit report substantially less daytime sleepiness and more refreshing sleep. By one to three months of consistent use, the cumulative effects on cognition, mood, and physical energy become apparent — often more clearly to family members than to the patient themselves.

The partner-notices-first phenomenon is worth flagging. Patients with chronic OSA often have adapted to chronic mild fatigue and cognitive fog over years and may not subjectively recognize how impaired their daytime function had become. Family members and bed partners, who interact with the patient daily and have a clearer external reference, frequently notice substantial changes in the first weeks — sharper conversations, better mood, more engagement, fewer nodding-off episodes during meals or evenings — before the patient themselves recognizes the shift. This is one reason that asking a partner to weigh in on whether the therapy is helping is often more informative than asking the patient alone.

Cardiovascular markers improve over a longer timeline. Blood pressure typically begins to fall within weeks of consistent use, with full effect at three to six months. Atrial fibrillation recurrence rates drop within months. The cardiovascular event-rate reduction observed in long-term cohort studies emerges over years of consistent use; CPAP shifts the trajectory of cardiovascular risk rather than producing immediate event prevention.

The diagnostic question for whether CPAP is "working" combines several markers: subjective improvement in daytime alertness, objective reduction in apnea events as measured by the device's built-in tracking, normalization of oxygen levels, and (over months) measurable changes in blood pressure, mood, and other cardiovascular markers. Most modern CPAP devices provide adherence and efficacy data through a manufacturer app or web portal, allowing both patient and clinician to track use and outcome over time.

When CPAP isn't the right answer (and what is)

For some patients, CPAP cannot be made to work despite reasonable trial of mask styles, pressure adjustments, and acclimation support. For others, CPAP works clinically but is unacceptable for travel, lifestyle, or relationship reasons. Several alternatives exist with their own evidence bases.

Oral appliance therapy. Custom-fitted dental devices that hold the lower jaw forward during sleep, mechanically opening the upper airway. Best evidence for mild-to-moderate OSA; can also help in moderate cases when CPAP is not tolerated. More portable than CPAP, generally better-tolerated, but somewhat less effective at higher OSA severities. The clinical principle: try OSA-trained dentistry, not generic mouthguards.

Hypoglossal nerve stimulation. An implanted device that stimulates the nerve controlling the tongue during sleep, opening the airway through muscular rather than pneumatic mechanism. Approved for selected patients with moderate-to-severe OSA who cannot tolerate CPAP, who meet specific anatomic and BMI criteria. More invasive (requires surgery to implant) but does not require nightly mask use.

Upper airway surgery. Several procedures exist for selected patients with specific anatomic obstruction — uvulopalatopharyngoplasty (UPPP), maxillomandibular advancement (MMA), and others. Outcomes vary substantially by patient selection; most effective when a specific anatomic obstruction has been identified. Best decision-making is made with a sleep medicine specialist working alongside a sleep-trained ENT or maxillofacial surgeon.

Weight loss. For overweight patients with OSA, substantial weight loss can meaningfully reduce OSA severity and in some mild cases produce resolution. Useful adjunct rather than substitute for direct treatment in moderate-to-severe disease. Bariatric surgery in selected patients can produce dramatic OSA improvement, though some patients remain CPAP-dependent even after major weight loss.

Positional therapy. For patients whose OSA is substantially worse on the back than on the side, devices that prevent supine sleep can produce meaningful improvement. Best in mild-to-moderate positional OSA; not sufficient alone for severe disease.

The decision among these is best made with a sleep specialist who can match approach to severity, anatomy, lifestyle, and tolerance. Given OSA's cardiovascular consequences, the clinical principle is that some effective treatment is preferable to no treatment when CPAP is not workable for an individual.

When to talk to your doctor

The honest framing on CPAP is that adherence problems are common, solvable, and worth working through rather than around. The following patterns warrant prompt attention from the prescribing clinician, sleep specialist, or DME provider:

• Mask fit problems (leaks, pressure points, skin breakdown) that haven't resolved within the first one to two weeks
• Persistent nasal symptoms or dryness despite humidification adjustment
• Tolerance difficulty with prescribed pressure that hasn't improved with acclimation
• Continued daytime sleepiness despite reasonable adherence — may indicate inadequate pressure or coexisting sleep disorder
• Substantial decline in adherence after initial successful use — often signals a fixable problem
• Travel, hospital, or illness disruption that has produced extended gaps in use
• Decision-making about whether to continue CPAP or pursue an alternative — best made with the prescribing sleep specialist rather than abandoning treatment unilaterally

The clinical message worth holding onto: CPAP is the most effective therapy for moderate-to-severe OSA, and the difficult cases of CPAP non-adherence rarely reflect inability to tolerate the device — they reflect mechanical or behavioral problems that have specific solutions when worked through with the right support. Persistence with the right help substantially outperforms abandoning the therapy.